Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
批准号:
7687186
负责人:
GENHONG CHENG
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-17 至 2009-06-30
关键词:
AccountingAcetaminophenAcute Liver FailureAdenovirusesAgonistAmericasAntiviral AgentsAntiviral ResponseAspirinBiologicalCellsCellular Metabolic ProcessChemosensitizationChildDNA VirusesDataDiseaseGene TargetingGenesGoalsHepatocyteHepatotoxicityHormonesHost DefenseHumanIRF3 geneImmuneImmune responseInfectionInfluenzaInterferon Type IInvestigationKnockout MiceLeadMediatingMetabolic DiseasesMetabolic PathwayMetabolismMethodsMolecularMusNuclearNuclear Hormone ReceptorsNuclear Receptor GeneNuclear ReceptorsPathway interactionsPatientsPharmaceutical PreparationsRNARXRReceptor GeneRepressionRoleSignal PathwaySignaling MoleculeSyndromeTestingTissue TransplantationToll-like receptorsVesicular stomatitis Indiana virusViralViral PathogenesisVirusVirus Diseasescell typegene repressionhuman IRF3 proteinimmunoregulationinterferon regulatory factor-3mouse modelnovelnovel strategiespathogenpreventprograms
中文摘要
这一应用的长期目标是更好地阐明其机制和生物学意义。
先天免疫反应和核激素受体在宿主防御中的串扰
感染和与病原体相关的代谢性疾病。我们实验室的初步数据发现了一种新的
干扰素调节因子3(IRF3)依赖而非I型干扰素非依赖途径
对病毒产物刺激或病毒感染的先天免疫反应,可导致强转录
抑制维甲酸X受体a(RXRA)。由于RXRA是大多数情况下的主要杂二聚体伙伴
核激素受体参与了许多细胞代谢过程,我们假设抑制
RXRA及其调控基因在病毒感染过程中的表达可能参与病毒相关性肝炎的发病
代谢性疾病,如热业S综合征,这是一种肝毒性疾病,当儿童服用
在病毒感染的情况下服用阿司匹林。此外,我们实验室的其他初步数据显示,
核激素受体激动剂可以抑制抗病毒基因的诱导,促进病毒复制。
因此,我们还假设,通过先天免疫反应抑制核激素受体
可能有助于适当的抗病毒反应。在本应用程序中,我们将确定角色和机制
抗病毒免疫反应和核激素受体之间的串扰
肝脏毒性和宿主对病毒感染的防御。我们计划首先开发模拟的老鼠模型
雷氏S综合征与对乙酰氨基酚所致肝毒性。然后我们将使用这些小鼠模型
为了确定由串扰引起的肝毒性的分子机制
抗病毒免疫反应和核激素受体。最后,我们将分析核的影响
激素受体及其激动剂对抗病毒先天免疫反应的抑制作用
天然免疫反应所产生的核激素受体是宿主防御病毒所必需的
感染。我们相信我们对先天免疫反应和核之间的串扰的研究
激素受体介导的新陈代谢不仅有助于我们理解
病毒诱导的代谢性疾病和药物诱导的免疫抑制,但也将提供新的策略
预防或治疗病毒感染患者及其相关代谢性疾病。
英文摘要
The long term goal of this application is to greater elucidate the mechanisms and biological significance of
crosstalk between the innate immune response and nuclear hormone receptors in host defense against
infections and in pathogen-associated metabolic diseases. Preliminary data in our lab has identified a novel
Interferon Regulatory Factor 3(IRF3)-dependent but type I interferon independent pathway induced during
innate immune response to viral product stimulation or viral infection, which can lead to strong transcriptional
repression of Retinoid X Receptor a (RXRa). As RXRa is the major heterodimer partner for most of the
nuclear hormone receptors involved in numerous cellular metabolic processes, we hypothesize that repression
of RXRa and its regulated genes during viral infections can contribute to the pathogenesis of viral associated
metabolic diseases such as Reye¿s Syndrome, a hepatotoxicity disease that occurs when children are given
aspirin in the context of a viral infection. Furthermore, additional preliminary data in our lab showed that
nuclear hormone receptor agonists can suppress the induction of antiviral genes and promote viral replications.
We therefore also hypothesize that repression of nuclear hormone receptors by the innate immune response
may contribute to a proper anti-viral response. In this application, we will determine the roles and mechanisms
of the crosstalk between anti-viral immune response and nuclear hormone receptors in both viral associated
hepatotoxicity and host defense against viral infections. We plan to first develop mouse models that mimic
Reye¿s Syndrome and acetaminophen (APAP)-induced hepatotoxicity. We will then use these mouse models
to determine the molecular mechanisms responsible for hepatotoxicity resulting from the crosstalk between
anti-viral immune response and nuclear hormone receptors. Finally, we will analyze the effects of nuclear
hormone receptors and their agonists on anti-viral innate immune responses to determine if the repression of
nuclear hormone receptors by innate immune response is necessary for the proper host defense against viral
infections. We believe our investigation of the crosstalk between the innate immune response and nuclear
hormone receptor-mediated metabolism will not only help us to understand the mechanisms responsible for
viral induced metabolic diseases and drug induced immuno-suppressions but will also provide novel strategies
to prevent or treat patients with viral infections and their associated metabolic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
-
批准号:10222540
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:GENHONG CHENG
-
依托单位:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
-
批准号:10174522
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:GENHONG CHENG
-
依托单位:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
-
批准号:10461773
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:GENHONG CHENG
-
依托单位:
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
-
批准号:10388193
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2018
-
负责人:GENHONG CHENG
-
依托单位:
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
-
批准号:9925059
-
项目类别:
-
资助金额:$75.04万
-
财政年份:2018
-
负责人:GENHONG CHENG
-
依托单位:
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
-
批准号:8039043
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2011
-
负责人:GENHONG CHENG
-
依托单位:
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
-
批准号:8208992
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2011
-
负责人:GENHONG CHENG
-
依托单位:
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation
-
批准号:8011751
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2010
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:7741382
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:8091282
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:8481502
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:8282723
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:7868050
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:7644341
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:7388575
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:8067083
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:7810716
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Viral Mediated Type I Interferon Induction
-
批准号:7587981
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2006
-
负责人:GENHONG CHENG
-
依托单位:
Viral Mediated Type I Interferon Induction
-
批准号:8636981
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2006
-
负责人:GENHONG CHENG
-
依托单位:
Viral Mediated Type I Interferon Induction
-
批准号:9458084
-
项目类别:
-
资助金额:$68.78万
-
财政年份:2006
-
负责人:GENHONG CHENG
-
依托单位:
国内基金
海外基金
SirT1在Acetaminophen诱发的药物性肝损伤中的作用及机制
-
批准号:81100281
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:黄卫锋
-
依托单位: